Alfredo
Carrato Mena
Profesor/a Emérito/a
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (11)
2020
-
A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective
ESMO Open, Vol. 5, Núm. 5
-
Bratislava Statement: Consensus recommendations for improving pancreatic cancer care
ESMO Open, Vol. 5, Núm. 6
2019
-
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy
Annals of Oncology, Vol. 30, Núm. 3, pp. 439-446
-
Working towards a consensus on the oncological approach of breakthrough pain: A Delphi survey of Spanish experts
Journal of Pain Research, Vol. 12, pp. 2349-2358
2017
-
Optimization of RAS/BRAF mutational analysis confirms improvement in patient selection for clinical benefit to anti-EGFR treatment in metastatic colorectal cancer
Molecular Cancer Therapeutics, Vol. 16, Núm. 9, pp. 1999-2007
2015
-
Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design
Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315
2014
-
Oncological translational research in the Spanish national health system: The INTRO study
Clinical and Translational Oncology, Vol. 16, Núm. 8, pp. 686-695
2011
-
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: A prospective study in a clinically-relevant spectrum of patients
European Journal of Epidemiology, Vol. 26, Núm. 3, pp. 229-236
2010
-
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
British Journal of Cancer, Vol. 103, Núm. 4, pp. 581-589
2009
-
Utility of p16 immunohistochemistry for the identification of Lynch syndrome
Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162
2000
-
The 18q21 region in colorectal and pancreatic cancer: Independent loss of DCC and DPC4 expression
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, Núm. 2, pp. 283-296